Is UTI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for UTI. It does not provide personalized investment advice.

UTI (Universal Technical Institute, Inc.) Stock Analysis - Financials

Universal Technical Institute, Inc. (UTI) is a publicly traded Consumer Defensive sector company. As of August 7, 2026, UTI trades at $28.08 with a market cap of $2.33B and a P/E ratio of 36.11. UTI moved +0.76% today. Year to date, UTI is +12.20%; over the trailing twelve months it is -16.61%. Its 52-week range spans $21.29 to $51.34. Analyst consensus is strong buy with an average price target of $42.60. Rallies surfaces UTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are UTI's key financials?

UTI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. UTI recently traded at $28.08. Market cap is $2.33B. P/E ratio is 36.11. Revenue is $868.99M.

UTI Key Metrics

Key financial metrics for UTI
Metric	Value
Price	$28.08
Market Cap	$2.33B
P/E Ratio	36.11
EPS	$0.78
Dividend Yield	0.02%
52-Week High	$51.34
52-Week Low	$21.29
Volume	990
Avg Volume	0
Revenue (TTM)	$868.99M
Net Income	$42.68M
Gross Margin	0.00%

UTI Analyst Consensus

5 analysts cover UTI: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.60.

Common questions about UTI

What are UTI's key financials?: UTI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. UTI recently traded at $28.08. Market cap is $2.33B. P/E ratio is 36.11. Revenue is $868.99M.
Is UTI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for UTI. It does not provide personalized investment advice.